- Home
- EIC vs ABSI Comparison
EIC vs ABSI Comparison
Compare EIC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIC
- ABSI
- Stock Information
- Founded
- EIC N/A
- ABSI 2011
- Country
- EIC United States
- ABSI United States
- Employees
- EIC N/A
- ABSI N/A
- Industry
- EIC Finance/Investors Services
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- EIC Finance
- ABSI Health Care
- Exchange
- EIC Nasdaq
- ABSI Nasdaq
- Market Cap
- EIC 349.4M
- ABSI 338.0M
- IPO Year
- EIC 2019
- ABSI 2021
- Fundamental
- Price
- EIC $13.78
- ABSI $2.67
- Analyst Decision
- EIC Strong Buy
- ABSI Strong Buy
- Analyst Count
- EIC 1
- ABSI 4
- Target Price
- EIC $17.50
- ABSI $8.75
- AVG Volume (30 Days)
- EIC 204.2K
- ABSI 4.1M
- Earning Date
- EIC 08-05-2025
- ABSI 08-13-2025
- Dividend Yield
- EIC 17.48%
- ABSI N/A
- EPS Growth
- EIC N/A
- ABSI N/A
- EPS
- EIC 0.55
- ABSI N/A
- Revenue
- EIC $51,224,692.00
- ABSI $4,815,000.00
- Revenue This Year
- EIC $42.67
- ABSI $81.76
- Revenue Next Year
- EIC $29.16
- ABSI $287.79
- P/E Ratio
- EIC $24.89
- ABSI N/A
- Revenue Growth
- EIC 68.61
- ABSI N/A
- 52 Week Low
- EIC $12.63
- ABSI $2.01
- 52 Week High
- EIC $16.71
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- EIC 59.85
- ABSI 46.51
- Support Level
- EIC $13.64
- ABSI $2.54
- Resistance Level
- EIC $13.92
- ABSI $2.92
- Average True Range (ATR)
- EIC 0.16
- ABSI 0.15
- MACD
- EIC 0.07
- ABSI 0.01
- Stochastic Oscillator
- EIC 96.83
- ABSI 41.86
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.